NYSEARCA:PSIL AdvisorShares Psychedelics ETF (PSIL) Price, Holdings, & News $16.42 +0.92 (+5.94%) Closing price 07/18/2025 04:10 PM EasternExtended Trading$16.37 -0.05 (-0.30%) As of 07/18/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PSIL alerts:Sign Up Key Stats Today's Range$15.57▼$16.5050-Day Range$11.65▼$16.4252-Week Range$7.14▼$16.50Volume34,489 shsAverage Volume15,030 shsMarket Capitalization$12.32 millionAssets Under Management$11.92 millionDividend Yield2.01%Net Expense Ratio0.99%Aggregate RatingModerate Buy ETF Overview The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares. Read More AdvisorShares Psychedelics ETF ExpensesTypePSILTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.60%0.57%0.56%0.51%0.53%Other Expenses2.35%0.57%0.56%0.59%0.56%Total Expense2.95%0.74%0.76%0.74%0.73%Fee Waiver-1.96%-0.76%-0.66%-0.71%-0.63%Net Expense0.99%0.60%0.63%0.58%0.60% Receive PSIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address PSIL ETF News HeadlinesAdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Shares Up 3.1% - What's Next?July 17 at 4:15 AM | americanbankingnews.comNo Trippin’: Trump Trade Pushes PSIL, VCAR HigherNovember 15, 2024 | finance.yahoo.comMiss This Window And You Miss EverythingThere’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the phase when momentum builds, news turns bullish, and markets ignite. Inside The Crypto Code Workshop, you’ll get the roadmap to ride this wave — and $10 in free Bitcoin just for showing up.July 20 at 2:00 AM | Crypto Swap Profits (Ad)DRUG Enhances Buzz for Psilocybin, Psychedelic ETFsOctober 18, 2024 | finance.yahoo.comAdvisorShares Psychedelics ETF (ARCA:PSIL), Short Interest ReportSeptember 12, 2024 | benzinga.comAdvisorShares Announces Reverse Split of ETFAugust 30, 2024 | finance.yahoo.comSee More Headlines PSIL ETF - Frequently Asked Questions How have PSIL shares performed this year? AdvisorShares Psychedelics ETF's stock was trading at $10.98 at the start of the year. Since then, PSIL stock has increased by 49.5% and is now trading at $16.42. How do I buy shares of AdvisorShares Psychedelics ETF? Shares of PSIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of AdvisorShares Psychedelics ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that AdvisorShares Psychedelics ETF investors own include Tilray Brands (TLRY), Bright Minds Biosciences (DRUG), Las Vegas Sands (LVS), NVIDIA (NVDA), Archer Aviation (ACHR), Blade Air Mobility (BLDE) and Blink Charging (BLNK). Fund Details IssuerAdvisorShares Fund NameAdvisorShares Psychedelics ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PSIL Inception Date9/15/2021 Fund ManagerDan S. Ahrens WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings27 Fund Statistics Assets Under Management$11.92 million Average Daily Volume$0.00 Discount/Premium0.53% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorAdvisorShares Investments, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume6 Put Options10 Call Options6 Short Interest13,900 shs Miscellaneous Outstanding Shares750,000Beta0.93 Creation Fee$500.00 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report Top 10 PSIL Holdingsatai Life Sciences (NASDAQ:ATAI)Holding Weight: 9.43%NRx Pharmaceuticals (NASDAQ:NRXP)Holding Weight: 8.06%Mind Medicine (MindMed) (NASDAQ:MNMD)Holding Weight: 7.69%Cybin Inc.Holding Weight: 7.28%Alkermes (NASDAQ:ALKS)Holding Weight: 7.11%Sage Therapeutics (NASDAQ:SAGE)Holding Weight: 7.00%COMPASS Pathways (NASDAQ:CMPS)Holding Weight: 5.86%GH Research (NASDAQ:GHRS)Holding Weight: 5.67%Neurocrine Biosciences (NASDAQ:NBIX)Holding Weight: 5.67%Quantum BioPharma Ltd.Holding Weight: 5.67%Full Holdings DetailsPSIL Sector ExposurePSIL Industry Exposure This page (NYSEARCA:PSIL) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
